Systematic Reviews & Meta-analysis
SR | Use of acupuncture for adult health conditions, 2013 to 2021.
14 Dec, 2022 | 14:54h | UTC
SR | Fundoplication in laparoscopic Heller’s cardiomyotomy for achalasia.
14 Dec, 2022 | 14:53h | UTCFundoplication in laparoscopic Heller’s cardiomyotomy for achalasia – Cochrane Library
SR | Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
14 Dec, 2022 | 14:51h | UTCTreatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins – Cochrane Library
Systematic Review | Management of infantile epilepsies.
13 Dec, 2022 | 14:18h | UTCManagement of Infantile Epilepsies – Agency for Healthcare Research and Quality
SR | Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis.
13 Dec, 2022 | 14:15h | UTCInhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis – Cochrane Library
Summary: Inhaling antibiotics to treat lung infection in people with cystic fibrosis – Cochrane Library
SR | Global prevalence and incidence of shoulder pain.
13 Dec, 2022 | 14:09h | UTC
SR | Skin care interventions in infants for preventing eczema and food allergy.
12 Dec, 2022 | 12:23h | UTCSkin care interventions in infants for preventing eczema and food allergy – Cochrane Library
Summary: Skin care interventions for preventing eczema and food allergy – Cochrane Library
Commentary on Twitter
Read our newest review on skin care interventions in infants for preventing eczema and food allergy! https://t.co/o8HtBXRVM5 pic.twitter.com/BPzsjJZvTf
— Cochrane Skin (@CochraneSkin) November 15, 2022
M-A | Allergen immunotherapy for atopic dermatitis.
9 Dec, 2022 | 13:24h | UTC
M-A | Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
9 Dec, 2022 | 13:20h | UTC
M-A | Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage.
9 Dec, 2022 | 13:17h | UTC
Commentary on Twitter
Meta-analysis finds mostly successful DOAC reversal with 4F-PCC (77%), andexanet alfa (AA)(75%), and idarucizumab (82%) in patients with ICH. 4F-PCC and AA had comparable success in factor Xa inhibitor reversal, mortality, and thromboembolic outcomes. #OA https://t.co/aieJd9h5jo
— JAMA Network Open (@JAMANetworkOpen) November 4, 2022
SR | Efficacy and safety of COVID‐19 vaccines.
8 Dec, 2022 | 13:04h | UTCEfficacy and safety of COVID‐19 vaccines – Cochrane Library
Summary: What are the benefits and risks of vaccines for preventing COVID-19? – Cochrane Library
Commentary: Are COVID-19 vaccines effective and safe? New Cochrane evidence – Evidently Cochrane
SR | Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation.
7 Dec, 2022 | 14:11h | UTC
SR | Non‐invasive positive pressure ventilation for central sleep apnea in adults.
7 Dec, 2022 | 14:09h | UTCNon‐invasive positive pressure ventilation for central sleep apnoea in adults – Cochrane Library
Summary: Non-invasive ventilation for people with central sleep apnoea – Cochrane Library
M-A | Pregnancy outcomes after first-trimester treatment with artemisinin derivatives vs. non-artemisinin antimalarials.
6 Dec, 2022 | 14:02h | UTC
Commentary on Twitter (thread – click for more)
#Malaria in early pregnancy can have severe consequences.
Though an effective treatment, artemisinin-based combination therapies (ACTs) have not been recommended in the first trimester due to safety concerns.
A study presents updated evidence on safety: https://t.co/zBF7CAMRyY pic.twitter.com/2xRNvfTfx8
— The Lancet (@TheLancet) December 2, 2022
M-A | Comparison of various regional analgesia methods in video-assisted thoracoscopic surgery.
5 Dec, 2022 | 00:10h | UTC
M-A | Treatment of depression after acute coronary syndrome.
5 Dec, 2022 | 00:03h | UTC
M-A | Efficacy and safety of COVID-19 inactivated vaccine.
1 Dec, 2022 | 14:00h | UTCEfficacy and safety of COVID-19 inactivated vaccine: A meta-analysis – Frontiers in Medicine
Collection of Cochrane evidence on diagnosing tuberculosis.
1 Dec, 2022 | 13:56h | UTCCollection of Cochrane evidence on diagnosing tuberculosis – Cochrane Library
M-A | Efficacy and safety of Roxadustat in patients with chronic kidney disease.
29 Nov, 2022 | 14:00h | UTCRelated:
M-A | Risk factors for knee osteoarthritis after traumatic knee injury.
29 Nov, 2022 | 14:02h | UTCCommentary: Risk factors for osteoarthritis after a knee injury – BJSM Blog
Commentary on Twitter
What can we do to reduce the risk of osteoarthritis after a knee injury?
Check out our evidence informed@recomemdations??
?open accesshttps://t.co/qkvrDWHJPC pic.twitter.com/jqbGZM4Z6Q
— OPTIKNEE (@OPTIKNEE) November 24, 2022
Clinical practice guidelines on palliative sedation around the world: a systematic review.
29 Nov, 2022 | 13:43h | UTC
SR | E-cigarettes are more effective than traditional nicotine-replacement methods in helping people quit smoking.
27 Nov, 2022 | 22:26h | UTCElectronic cigarettes for smoking cessation – Cochrane Library
News Release: E-cigarettes are more effective than nicotine-replacement therapy in helping smokers quit – University of Oxford
Commentaries:
Commentary on Twitter
Published today! Updated w/ 17 new studies @CochraneLibrary living review of #ecig to #QuitSMOKING. Now high certainty evidence nicotine #vapes help more people to quit at 6 mths+ than NRT. @CRUK_Policy funded https://t.co/68FBih1nVg pic.twitter.com/euKXCxLJLk
— CochraneTAG (@CochraneTAG) November 17, 2022
M-A | Effectiveness of home-based exercise delivered by digital health in older adults.
27 Nov, 2022 | 22:20h | UTC
Commentary on Twitter
Effectiveness of home-based exercise delivered by digital health in older adults: a systematic review and meta-analysis
????https://t.co/OYXM6tzNGr pic.twitter.com/VNnURqQQHz
— Physio Meets Science (@PhysioMeScience) November 16, 2022
SR | Pharmacological interventions for people with borderline personality disorder.
27 Nov, 2022 | 22:11h | UTCPharmacological interventions for people with borderline personality disorder – Cochrane Library
SR | Interventions for the long‐term prevention of hereditary angioedema attacks.
27 Nov, 2022 | 22:12h | UTCInterventions for the long‐term prevention of hereditary angioedema attacks – Cochrane Library
Summary: Drug treatments for the prevention of attacks of hereditary angioedema – Cochrane Library
Commentary on Twitter
New #CochraneEvidence – Interventions for the long‐term prevention of #HereditaryAngioedema attacks #HAE @CochraneUK @CochraneLibrary @US_HAEA @UCSDHealth @HAEDAY @VSGBI @ChariteBerlin https://t.co/jYYjmG1eGH pic.twitter.com/2z522Bw5iZ
— CochraneVasc (@CochraneVasc) November 7, 2022